Akihide Wakamatsu
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan.
Journal: Neuropsychopharmacology reports
Published: February 28, 2025
Treatment Persistence of Paliperidone Palmitate 3-Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis.
Journal: Neuropsychopharmacology reports
Published: January 16, 2025
Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan.
Journal: Asian journal of psychiatry
Published: December 18, 2024
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients' and physicians' perspectives.
Journal: BMC psychiatry
Published: July 30, 2024
Clinical effectiveness of paliperidone palmitate 3-monthly and 1-monthly as monotherapy in patients with schizophrenia: A retrospective cohort study based on the Medicaid claims database.
Journal: Neuropsychopharmacology reports
Published: June 03, 2024
A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database.
Journal: Neuropsychopharmacology reports
Published: July 12, 2023
Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in Japan.
Journal: Asian journal of psychiatry
Published: May 11, 2023
Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression.
Journal: Psychiatry and clinical neurosciences
Published: December 21, 2021
Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: January 12, 2021
The Effects of Paliperidone Palmitate 1 Month on the Employment Status and Social Functioning of Patients with Schizophrenia.
Journal: Innovations in clinical neuroscience
Published: June 18, 2020
Budget impact analysis of long acting injection for schizophrenia in Japan.
Journal: Journal of medical economics
Published: April 10, 2020
The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: July 08, 2015
Last Updated: 09/26/2026